Front. Pharmacol.Frontiers in PharmacologyFront. Pharmacol.1663-9812Frontiers Media S.A.113368610.3389/fphar.2022.1133686PharmacologyCorrectionCorrigendum: Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysisGao et al.10.3389/fphar.2022.1133686GaoHongliang123†WuJing1†SunZhenyu4†ZhangFurong1ShiTianshu5LuKe6QianDongfu4YinZicheng7ZhaoYinjuan3*QinJian1*XueBin1*1Core Laboratory, Sir Run Run Hospital, Nanjing Medical University, Nanjing, China2School of Clinical Medicine, Wannan Medical College, Wuhu, China3Collaborative Innovation Center of Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing, China4School of Health Policy and Management, Center for Global Health, Nanjing Medical University, Nanjing, China5State Key Laboratory of Pharmaceutical Biotechnology, Department of Sports Medicine and Adult Reconstructive Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China6Research Center for Computer‐Aided Drug Discovery, Chinese Academy of Sciences, Shenzhen, China7Nanjing Foreign Language School, Nanjing, China
Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland
*Correspondence: Yinjuan Zhao, zhaoyinjuan@njfu.edu.cn; Jian Qin, qinjian@njmu.edu.cn; Bin Xue, xuebin@njmu.edu.cn
These authors have contributed equally to this work
This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis by Gao H, Wu J, Sun Z, Zhang F, Shi T, Lu K, Qian D, Yin Z, Zhao Y, Qin J and Xue B (2022), .Front. Pharmacol. 13:1062249. doi: 10.3389/fphar.2022.1062249lecithin cholesterol acyltransferasephysiologicalemerging trendsriskbibliometrics
In the published article, there was an error in the Funding statement. The funding statement for the National Natural Science Foundation of China was displayed as “32071145”.
The correct statement is “the National Natural Science Foundation of China, 32071142, 32271187.’’
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.